Histological examination | OSNA assay | |
---|---|---|
Tumour topography | Exhaustive study of tissue topography and detection of extracapsular extension | The assay do not enable the study of tumour topography, but adjacent lymph node tissue is analysed by complementary histological procedures |
Morphological study | Study of metastatic deposits and isolated neoplastic cells. Minimisation of false positives like benignant epithelial inclusions (exceptional in mediastinal lymph nodes) | The assay do not enable the study of cellular and histological lymph node morphology |
Sensibility | Lower limit of detection | More accuracy than histological procedures. Detection of occult micrometastasis |
Whole lymph node analysis | Risk of sample bias. Slow and laborious study of whole lymph node | Fast, feasible and accurate whole lymph node analysis. Minimisation of false negatives |
KRT19 quantification | Relative quantification of KRT19 expression by digital pathology | Absolute quantification of KRT19 expression that correlates with metastatic foci. The assay also allows the possibility of detecting total tumour load |
Assay rapidity/Workflow | Fast analysis of a single intraoperative slide (less than 15 min) | Fast analysis of the whole lymph node (less than 25 min) |
Methodology | Standardised procedures. Immunohistochemical scores and histological examination not protocolled | Normalised and standardised protocols. Unbiased results |
Cost-effectiveness | Higher cost of time, personnel and resources for diagnostic | Lower cost-effectiveness ratio |
Remnant sample | Remnant samples are available for histological and molecular analysis | Remaining lymph node lysates are available for subsequent molecular analysis |